协同制药(SGYP)

0.03 %

简介：Synergy Pharmaceuticals Inc.于2005年11月15日在佛罗里达州注册成立，是一家生物制药公司，主要集中于药物来治疗胃肠道的障碍和疾病的发展。公司主导候选产品是首款治疗女性慢性便秘口服药（plecanatide），一个一种鸟苷酸环化酶C(GC-C)受体激动剂，用于治疗胃肠道疾病，主要是慢性特发性便秘，或慢性特发性便秘和便秘型肠易激综合征，或肠易激综合征-C。慢性特发性便秘和肠易激综合征-C是折磨全世界数百万患者的功能性胃肠病。


公司网站：
http://www.synergypharma.com

公司地址：420 Lexington Avenue Suite 2012 New York New York 10170
公司电话：1-212-2970020
今开：昨收：0.03
最高：最低：
涨停价：跌停价：
总市值：7441119

协同制药的最新讨论

协同制药的公告

公告

$协同制药(SGYP)$ 8-K - Current report Filed: 2019-05-02 AccNo: 0001104659-19-026255 Size: 85 KBItem 1.03: Bankruptcy or ReceivershipItem 3.03: Material Modifications to Rights of Security HoldersItem 5.01: Changes in Control of RegistrantItem 5.02: Departure of Directors or C...

公告

$协同制药(SGYP)$ 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities Filed: 2019-05-02 AccNo: 0001354457-19-000244 Size: 4 KB 网页链接

公告

$协同制药(SGYP)$ 8-K - Current report Filed: 2019-04-29 AccNo: 0001104659-19-024305 Size: 1 MBItem 1.03: Bankruptcy or ReceivershipItem 3.03: Material Modifications to Rights of Security HoldersItem 7.01: Regulation FD DisclosureItem 8.01: Other EventsItem 9.01: Financial Sta...

公告

$协同制药(SGYP)$ 8-K - Current report Filed: 2019-04-02 AccNo: 0001104659-19-019180 Size: 1 MBItem 1.03: Bankruptcy or ReceivershipItem 9.01: Financial Statements and Exhibits 网页链接

公告

$协同制药(SGYP)$ 8-K - Current report Filed: 2019-03-14 AccNo: 0001104659-19-014897 Size: 1 MBItem 1.03: Bankruptcy or ReceivershipItem 9.01: Financial Statements and Exhibits 网页链接

公告

$协同制药(SGYP)$ 8-K - Current report Filed: 2019-03-08 AccNo: 0001104659-19-013525 Size: 22 KBItem 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 网页链接

公告

$协同制药(SGYP)$ 8-K - Current report Filed: 2019-03-06 AccNo: 0001104659-19-013133 Size: 167 KBItem 2.01: Completion of Acquisition or Disposition of AssetsItem 9.01: Financial Statements and Exhibits 网页链接

公告

$协同制药(SGYP)$ 8-K - Current report Filed: 2019-03-04 AccNo: 0001104659-19-012191 Size: 42 KBItem 7.01: Regulation FD DisclosureItem 9.01: Financial Statements and Exhibits 网页链接

公告

$协同制药(SGYP)$ 8-K - Current report Filed: 2019-02-27 AccNo: 0001104659-19-010771 Size: 40 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain OfficersItem 8.01: Other EventsIt...